Pfizer Inc
NYSE: PFE
$25.83
+$0.06 (+0.2%)
Closing Price on November 27, 2024
PFE Articles
As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.
Published:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
As of the most recently reported period, short sellers favored Pfizer, Microsoft and Intel above all other Dow stocks.
Published:
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Published:
Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin out part of its operations. Executing this effort may create some operational uncertainty inside of...
Published:
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this week.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.
Published:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline expectation of more than 7% gains in 2020.
Published: